EspañolChineseOther languages

 

HomeAbout UsNews & EventsMediaContact UsDonateAdvocateWalkShopAction Center

24/7 Helpline:

800.272.3900

Find us anywhere

Our vision is a world without Alzheimer's

Action Item Index






Alzheimer's Breakthrough Act

Scientists believe we are at a tipping point on Alzheimer’s research.  We have the ideas, the technology and the will.  But we do not have a commitment from the federal government.

Over the next 40 years, caring for individuals with Alzheimer’s will cost American society $20 trillion –including $15 trillion to Medicare and Medicaid.

For every $28,000 the federal government spends on care for Alzheimer’s disease patients, it only spends $100 on Alzheimer’s disease research.  Federal funding of Alzheimer’s research is an inadequate $450 million, and does not reflect the escalating national epidemic of Alzheimer’s disease.

The Alzheimer’s Breakthrough Act of 2011 (H.R. 1897) would advance breakthrough treatments for people living with Alzheimer’s by requiring a federal commitment Alzheimer’s disease research. 

The Alzheimer’s Breakthrough Act would require the Director of the National Institutes of Health (NIH) to accelerate the development of treatments that prevent, cure, or slow the progression of Alzheimer’s disease and reduce the financial burden of Alzheimer’s on federally funded programs and families.  The bill requires the director of NIH to develop a research plan to overcome Alzheimer’s disease and to make annual appropriations and budget requests to accomplish the science necessary to achieve our goal – a world without Alzheimer’s.

The Alzheimer’s Breakthrough Act (H.R. 1897) would:

  • Make Alzheimer’s research a priority at the National Institutes of Health (NIH) by:
    • pursuing emerging scientific and research opportunities across the 27 Institutes and Centers at NIH
    • adopting the research recommendations from the forthcoming National Alzheimer’s Plan

  • Create public-private partnerships to develop treatments and a cure through innovative approaches to Alzheimer’s research.

  • Require the leadership at NIH to provide the funding necessary to get the job done – or explain to Congress why they are not.

Resources:

If you have the opportunity to speak to a member of Congress about this legislation, please report it at: www.alz.org/congressionalreportform

Learn about our other top legislative priority at: www.alz.org/hopeact